AGP Executive Report
Last update: a day agoASCO 2026 Drug Updates: Oral mezigdomide plus carfilzomib and dexamethasone cut progression or death risk in relapsed/refractory multiple myeloma (SUCCESSOR-2), while updated EV-302/KEYNOTE-A39 data kept showing strong overall survival gains for enfortumab vedotin plus pembrolizumab in first-line urothelial cancer. Cancer Care & Patient Experience: A COMPETE secondary analysis found 177Lu-edotreotide improved health-related quality of life versus everolimus in GEP-NETs, and frontMIND results supported tafasitamab plus lenalidomide with R-CHOP for high-risk DLBCL/HGBL. HR & Workforce Policy: Cass County department heads flagged rising healthcare costs, staffing shortages, recruitment/retention pressure, and cybersecurity needs. Workplace Trends: A JLL global report found UK employees spend fewer days in the office than global peers (2.8 vs 3.2). Public Sector Scheduling: Dubai expanded its “Our Flexible Summer” model to reduce workdays during extreme heat. Global Talent & Inclusion: A UK legal sector piece highlights persistent underrepresentation of Black lawyers and the cost barriers to entry. Demographics: Bulgaria’s career forum tackled the demographic crisis with a focus on childcare capacity and reducing working-age mortality.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
